Market Update | Advanced Micro Devices, Walmart, Williams-Sonoma, Anthropic, NEXTDC, Monash IVF, Bell Financial, Arena REIT, Pro Medicus, Orica, Mineral Resources
Market Update | Advanced Micro Devices, Walmart, Williams-Sonoma, Anthropic, NEXTDC, Monash IVF, Bell Financial, Arena REIT, Pro Medicus, Orica, Mineral Resources
About this video
The Australian sharemarket was heading for another deeply negative session, with the ASX 200 opening around 0.75% lower as global technology stocks came under renewed selling pressure. Wall Street's major indices fell more than 2%, with early optimism surrounding Anthropic's record-breaking Nasdaq debut giving way to profit-taking and concerns about elevated artificial intelligence valuations. Investors also monitored rising bond yields, a stronger US dollar and renewed movements in oil and gold prices.
Technology stocks faced renewed pressure on Wall Street as investors reassessed AI valuations and the sustainability of heavy investment in artificial intelligence infrastructure. Semiconductor shares, including AMD, were caught up in the broader sell-off as early optimism around Anthropic's IPO faded.
Walmart shares slipped despite the retailer exceeding third-quarter profit expectations and raising its sales outlook. The market reaction highlights the cautious sentiment weighing on US equities, even as parts of the consumer sector continue to demonstrate resilience.
Williams-Sonoma fell after reporting softer same-store sales, with the company continuing to face pressure from a weaker housing market. The result added to concerns about consumer demand across the home furnishings sector.
Anthropic made a historic Nasdaq debut after raising US$81.3 billion through its blockbuster IPO, making it the largest public listing in history. Shares were priced at US$83 each and initially surged around 34%, before paring gains to finish approximately 17% higher.
The AI company briefly exceeded a US$2 trillion valuation, attracting significant investor interest despite broader technology-sector volatility. The listing also drew attention from Australian investors, with some retail and private wealth clients reportedly receiving allocations of only around 7% of the shares they applied for.
NEXTDC upgraded its FY27 revenue and earnings guidance ahead of its annual general meeting, following a review of its capital expenditure program.
Net revenue is now forecast between $485 million and $500 million, while underlying earnings guidance increased to approximately $260 million to $275 million. The upgrade was supported by stronger sales outside its delayed M3 facility in Melbourne.
Capital expenditure guidance remains unchanged at $4.5 billion to $5 billion, with the company pausing certain contracted projects and new land purchases as it focuses on delivering existing capacity.
Monash IVF warned that full-year underlying profit will be materially below last year's result and market expectations, sending shares sharply lower by approximately 22%.
The downgrade follows a 3.2% contraction in the Australian IVF market during the first quarter, alongside rising rental, wage, insurance and supplier costs. The company also said planned productivity savings would take longer than expected to materialise.
Bell Financial disclosed a data breach after hackers gained unauthorised access to a limited number of its IT systems and some client information.
The company said the incident had been contained, client assets remained safe and business operations were continuing as usual.
Arena REIT launched an on-market share buyback of up to $50 million, funded by proceeds from recent property sales. The group has contracted eight properties for sale so far this financial year, generating approximately $32 million.
The company also reaffirmed its full-year distribution guidance of 20 cents per security.
Pro Medicus secured a 10-year contract worth approximately US$120 million with New York City Health and Hospitals, the US public health system.
Under the transaction-based agreement, Pro Medicus' US subsidiary will deploy its cloud-based Visage 7 imaging platform across the hospital network, further expanding its presence in the US healthcare market.
Orica confirmed it has progressed to the second stage of a competitive sales process to acquire a mining-focused technology and chemicals business. The company stressed that discussions remain at an early stage, with no further details provided.
Mineral Resources has appointed Michael Ellis as its new chief financial officer, recruiting the executive from rival contractor Parenti Global.
Overall, markets remain under pressure as investors reassess technology valuations and the scale of investment flowing into artificial intelligence. Locally, company-specific developments ranged from NEXTDC's upgraded earnings outlook and Pro Medicus' major US contract to Monash IVF's profit warning, highlighting a mixed corporate backdrop.